Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
about
Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Argatroban anticoagulation in critically ill patients.Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.Prefilter bivalirudin for preventing hemofilter occlusion in continuous renal replacement therapy.The direct thrombin inhibitor argatroban: a review of its use in patients with and without HIT.Thrombocytopenia following percutaneous coronary intervention.Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.Pharmacology of argatroban.Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.Clinical experience with argatroban for heparin-induced thrombocytopenia in a large teaching hospital.The Pharmacotherapy of Heparin-Induced Thrombocytopenia (HIT) : A Review of Contemporary Therapeutic Challenges in Clinical Practice.Bleeding risk factors associated with argatroban therapy in the critically ill.Argatroban dose reductions for suspected heparin-induced thrombocytopenia complicated by child-pugh class C liver disease.Heparin-induced thrombocytopenia associated with acute liver graft failure.Non-recovery of ACT in a patient with heparin-induced thrombocytopenia type II during mitral valve replacement using argatroban anticoagulation.Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type IIHow we manage patients with heparin induced thrombocytopenia.Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy.Early initiation of argatroban therapy in the management of acute superior mesenteric venous thrombosis.Superficial vein thrombosis.
P2860
Q33373700-F1D99E5D-3A4E-44F2-AC52-DCD23930C651Q33374919-C43C999B-D133-41AD-B775-2C326678C173Q33375376-FD3A8411-5F7F-4601-B7CF-80AB2BCB0F4CQ33380780-A644CADB-94A8-4A33-B9C8-B3F459876DF1Q33385297-4E988E11-CD37-447B-9AD4-C2EC905C0A52Q33385970-E6E9D63E-0D0F-4389-8FCD-2EEF290E14DAQ33387648-B7D26952-19CF-490B-BBA7-F65F67A1F472Q33389707-1FC63946-649C-456E-A5C1-B94A7A91AAF0Q33392860-5B73449E-1C3C-4D63-B720-B1A6DF05CACCQ33393015-1E8F1910-F9C2-43CF-BE6C-2E49EC5C7380Q33400597-964E9947-1F0A-4733-A876-1E165E1EF73AQ33401236-F77AE262-E828-4298-A14B-2DDAD2486B24Q33402036-8F6DD3EF-27E6-448F-8A30-1E54BE7214C3Q33403844-C10CBFE4-A4AC-49ED-A467-9102DDAF8318Q33404597-E172D9BE-02F9-44FD-999D-5380AF99FE9DQ33407767-5B8B78CB-B71E-4CDF-B2C8-E698CEE30B96Q33417258-C6178CF0-F2B8-49AF-A634-F542C06C55DCQ33431626-F3734CA4-6653-4B0D-9193-734558B3BD65Q38463548-92502241-2315-4487-9AD0-3830E10EA822Q42293011-57054FA6-5E7D-4B7B-9407-BC2C52088ED4Q43905870-36E7B2EF-264E-4456-8497-951A1DC8B3A7
P2860
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
@ast
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
@en
type
label
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
@ast
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
@en
prefLabel
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
@ast
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
@en
P2093
P356
P1433
P1476
Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.
@en
P2093
David McCollum
Marcie J Hursting
Robert L Levine
P304
P356
10.1378/CHEST.129.5.1167
P407
P577
2006-05-01T00:00:00Z